Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 11/2011

01-11-2011 | Brief Communication

Liver Transplantation Trends in the HIV Population

Authors: Nyingi M. Kemmer, Kenneth E. Sherman

Published in: Digestive Diseases and Sciences | Issue 11/2011

Login to get access

Abstract

There is a paucity of information on the utilization patterns of liver transplantation (LT) for HIV-positive individuals. The aim of this study is to examine the trends in LT of HIV patients in the US. This study was a retrospective analysis using the UNOS database (1999–2008). There were 135 HIV-positive patients. There was a steady increase in the number of LT recipients over time as well as regional variation. Ethnic minorities accounted for 33.3% and there was no ethnic difference in survival. Though LT for HIV-positive patients is on the rise, significant variations exist in patient demographics, geographic location, and insurance payer.
Literature
1.
Weber R, Sabin CA, Friis-Moller N, et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med. 2006;166:1632–1641.PubMedCrossRef
2.
Pineda JA, Romero-Gomez M, Diaz-Garcia F, et al. HIV coinfection shortens the survival of patients with hepatitis c virus-related decompensated cirrhosis. Hepatology. 2005;41:779–789.PubMedCrossRef
3.
Mindikoglu AL, Regev A, Magder LS. Impact of human immunodeficiency virus on survival after liver transplantation: analysis of United Network of Organ Sharing database. Transplantation. 2008;85:359–368.PubMedCrossRef
4.
Norris S, Taylor C, Muiesan P, et al. Outcomes of liver transplantation in HIV-infected individuals: the impact of HCV and HBV infection. Liver Transpl. 2004;10:1271–1278.PubMedCrossRef
5.
Duclos-Vallee JC, Teicher E, Vittecoq D, Samuel D. Liver transplantation for patients infected with both HIV and HCV or HIV and HBV. Med Sci (Paris). 2007;23:723–728.CrossRef
6.
Roland ME, Barin B, Carlson L, et al. HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transpl. 2008;8:355–365.CrossRef
7.
Stock PG, Roland ME. Evolving clinical strategies for transplantation in the HIV-positive recipient. Transplantation. 2007;84:563–571.PubMedCrossRef
8.
9.
Sherman KE, Peters M, Koziel MJ. HIV and liver disease forum: conference proceedings. Hepatology. 2007;45:1566–1577.PubMedCrossRef
10.
Giordano TP, Kramer JR, Souchek J, Richardson P, El-Serag HB. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992–2001. Arch Intern Med. 2004;164:2349–2354.PubMedCrossRef
11.
Patel P, Hanson DL, Sullivan PS, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992–2003. Ann Intern Med. 2008;148:728–736.PubMed
12.
Castellares C, Barreiro P, Martin-Carbonero L, et al. Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome. J Viral Hepat. 2008;15:165–172.PubMed
13.
Rodriguez-Torres M, Govindarajan S, Diago M, et al. Hepatic steatosis in patients with chronic hepatitis C virus genotype 2 or 3 does not affect viral response in patients treated with peginterferon alpha-2a (40 kD) (PEGASYS) plus ribavirin (COPEGUS) for 16 or 24 weeks. Liver Int. 2009;29:237–241.PubMedCrossRef
14.
Martin-Carbonero L, de Ledinghen V, Moreno A, et al. Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection. J Viral Hepat. 2009;16:790–795.PubMedCrossRef
15.
Sulkowski MS, Mehta SH, Torbenson MS, et al. Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults. AIDS. 2007;21:2209–2216.PubMedCrossRef
16.
Yoo HY, Galabova V, Edwin D, Thuluvath PJ. Socioeconomic status does not affect the outcome of liver transplantation. Liver Transpl. 2002;8:1133–1137.PubMedCrossRef
17.
Kemmer N, Zacharias V, Kaiser TE, Neff GW. Access to liver transplantation in the meld era: role of ethnicity and insurance. Dig Dis Sci. 2008;54:1794–1797.PubMedCrossRef
18.
Thamer M, Henderson SC, Ray NF, Rinehart CS, Greer JW, Danovitch GM. Unequal access to cadaveric kidney transplantation in California based on insurance status. Health Serv Res. 1999;34:879–900.PubMed
19.
Winkelmayer WC, Glynn RJ, Levin R, Owen W Jr, Avorn J. Late referral and modality choice in end-stage renal disease. Kidney Int. 2001;60:1547–1554.PubMedCrossRef
20.
Cass A, Cunningham J, Snelling P, Ayanian JZ. Late referral to a nephrologist reduces access to renal transplantation. Am J Kidney Dis. 2003;42:1043–1049.PubMedCrossRef
21.
Kemmer N, Safdar K, Kaiser T, Zacharias V, Neff GW. Impact of geographic location on access to liver transplantation among ethnic minorities. Transplantation. 2008;85:166–170.PubMedCrossRef
22.
Muir AJ, Sanders LL, Heneghan MA, Kuo PC, Wilkinson WE, Provenzale D. An examination of factors predicting prioritization for liver transplantation. Liver Transpl. 2002;8:957–961.PubMedCrossRef
23.
McCormick PA, O’Rourke M, Carey D, Laffoy M. Ability to pay and geographical proximity influence access to liver transplantation even in a system with universal access. Liver Transpl. 2004;10:1422–1427.PubMedCrossRef
24.
Gill JS, Hussain S, Rose C, Hariharan S, Tonelli M. Access to kidney transplantation among patients insured by the United States department of veterans affairs. J Am Soc Nephrol. 2007;18:2592–2599.PubMedCrossRef
25.
Yoo HY, Thuluvath PJ. Outcome of liver transplantation in adult recipients: influence of neighborhood income, education, and insurance. Liver Transpl. 2004;10:235–243.PubMedCrossRef
26.
Heslin KC, Andersen RM, Ettner SL, Cunningham WE. Racial and ethnic disparities in access to physicians with HIV-related expertise. J Gen Intern Med. 2005;20:283–289.PubMedCrossRef
27.
28.
Kroeker KI, Bain VG, Shaw-Stiffel T, Fong TL, Yoshida EM. Adult liver transplant survey: policies towards eligibility criteria in Canada and the United States 2007. Liver Int. 2008;28:1250–1255.PubMedCrossRef
29.
Cooper CL, DeForest J, Gill J, Lalonde R. Barriers preventing liver transplantation in Canadians with HIV-infection–perceptions of HIV specialists. Can J Gastroenterol. 2007;21:179–182.PubMed
30.
Halpern SD, Asch DA, Shaked A, Stock PG, Blumberg E. Determinants of transplant surgeons’ willingness to provide organs to patients infected with HBV, HCV or HIV. Am J Transpl. 2005;5:1319–1325.CrossRef
31.
Kemmer N, Safdar K, Kaiser TE, Zacharias V, Neff GW. Liver transplantation trends for older recipients: regional and ethnic variations. Transplantation. 2008;86:104–107.PubMedCrossRef
32.
Moylan CA, Brady CW, Johnson JL, Smith AD, Tuttle-Newhall JE, Muir AJ. Disparities in liver transplantation before and after introduction of the meld score. JAMA. 2008;300:2371–2378.PubMedCrossRef
33.
Reid AE, Resnick M, Chang Y, Buerstatte N, Weissman JS. Disparity in use of orthotopic liver transplantation among blacks and whites. Liver Transpl. 2004;10:834–841.PubMedCrossRef
34.
French AL, Gawel SH, Hershow R, et al. Trends in mortality and causes of death among women with HIV in the United States: a 10-year study. J Acquir Immune Defic Syndr. 2009;51:399–406.PubMedCrossRef
35.
Whitmore SK, Satcher AJ, Hu S. Epidemiology of HIV/aids among non-Hispanic black women in the United States. J Natl Med Assoc. 2005;97:19S–24S.PubMed
36.
Arya M, Behforouz HL, Viswanath K. African American women and HIV/aids: a national call for targeted health communication strategies to address a disparity. AIDS Read. 2009;19:79–84.PubMed
37.
Smith AK, Ladner D, McCarthy EP. Racial/ethnic disparities in liver transplant surgery and hospice use: parallels, differences, and unanswered questions. Am J Hosp Palliat Care. 2008;25:285–291.PubMedCrossRef
38.
Nair S, Eustace J, Thuluvath PJ. Effect of race on outcome of orthotopic liver transplantation: a cohort study. Lancet. 2002;359:287–293.PubMedCrossRef
39.
Ananthakrishnan AN, Saeian K. Racial differences in liver transplantation outcomes in the meld era. Am J Gastroenterol. 2008;103:901–910.PubMedCrossRef
40.
Costigliola P, Tumietto F, Zagnoli A, Chiodo F. Need for liver transplant in HIV-positive patients: first results of a specific survey in Italy, project host. AIDS. 2003;17:2119–2121.PubMedCrossRef
41.
Ragni MV, Eghtesad B, Schlesinger KW, Dvorchik I, Fung JJ. Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease. Liver Transpl. 2005;11:1425–1430.PubMedCrossRef
42.
Vibert E, Duclos-Vallee JC, Ghigna MR, et al. Liver transplantation for hepatocellular carcinoma: the impact of human immunodeficiency virus infection. Hepatology. 2011;53:475–482.PubMedCrossRef
43.
Baccarani U, Adani GL, Tavio M, Viale P. Liver transplantation for hepatocellular carcinoma: the impact of human immunodeficiency virus infection–21 plus 13. Hepatology. 2011;53:2138. author reply 2138–2139.PubMedCrossRef
44.
Miro JM, Torre-Cisnero J, Moreno A, et al. GESIDA/GESITRA-SEIMC, PNS and ONT consensus document on solid organ transplant (SOT) in HIV-infected patients in Spain (March, 2005). Enferm Infecc Microbiol Clin. 2005;23:353–362.PubMedCrossRef
45.
O’Grady J, Taylor C, Brook G. Guidelines for liver transplantation in patients with HIV infection (2005). HIV Med. 2005;6:149–153.PubMedCrossRef
46.
Baccarani U, Adani GL, Bragantini F, et al. Long-term outcomes of orthotopic liver transplantation in human immunodeficiency virus-infected patients and comparison with human immunodeficiency virus-negative cases. Transpl Proc. 2011;43:1119–1122.CrossRef
47.
Di Benedetto F, Tarantino G, De Ruvo N, et al. University of Modena experience in HIV-positive patients undergoing liver transplantation. Transpl Proc. 2011;43:1114–1118.CrossRef
Metadata
Title
Liver Transplantation Trends in the HIV Population
Authors
Nyingi M. Kemmer
Kenneth E. Sherman
Publication date
01-11-2011
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 11/2011
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-011-1867-8

Other articles of this Issue 11/2011

Digestive Diseases and Sciences 11/2011 Go to the issue

Original Article

The Causes and Outcome of Acute Pancreatitis Associated with Serum Lipase >10,000 U/L

Case Report

Focal Fat Masquerading as Malignancy in the Liver Graft of a Post-Transplant Patient

Original Article

Epigenetic Inactivation of the SFRP1 Gene in Esophageal Squamous Cell Carcinoma

Original Article

Effects of Bifidobacterium infantis 35624 on Post-Inflammatory Visceral Hypersensitivity in the Rat

Original Article

Relationship of Pancreatic Mass Size and Diagnostic Yield of Endoscopic Ultrasound-Guided Fine Needle Aspiration

Original Article

Risk of Functional Gastrointestinal Disorders in U.S. Military Following Self-Reported Diarrhea and Vomiting During Deployment
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits